Hasil Pencarian - Ephraim J Fuchs

  • Menampilkan 1 - 11 hasil dari 11
Perbaiki Hasil
  1. 1
    Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched Transplantation

    Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched Transplantation oleh Shannon R. McCurdy, Ephraim J. Fuchs

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?

    How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation? oleh Ying-Jun Chang, Leo Luznik, Ephraim J. Fuchs, Xiao-Jun Huang

    Diterbitkan 2016-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide

    Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide oleh Ashley Munchel, Chimen Kesserwan, Heather J. Symons, Leo Luznik, Yvette L. Kasamon, Richard J. Jones, Ephraim J. Fuchs

    Diterbitkan 2011-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia

    The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia oleh Michael M Boyiadzis, Ivan Aksentijevich, Daniel A Arber, Renier J Brentjens, Ephraim J Fuchs, Linda J Fukas, Steven D Gore, Mark R Litzow, John M Pagel, Martin S Tallman

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

    Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide oleh Yvette L. Kasamon, Richard F. Ambinder, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Javier Bolaños-Meade, Mark J. Levis, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, William H. Matsui, Ivan Borrello, Robert A. Brodsky, Richard J. Jones, Leo Luznik

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70

    Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70 oleh Philip H. Imus, Hua-Ling Tsai, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Douglas E. Gladstone, Patrick Lowery, Richard F. Ambinder, Ivan M. Borrello, Lode J. Swinnen, Nina Wagner-Johnston, Christian B. Gocke, Syed Abbas Ali, F.Javier Bolaños-Meade, Ravi Varadhan, Richard J. Jones

    Diterbitkan 2019-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide

    Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide oleh Shannon R. McCurdy, Mei-Jie Zhang, Andrew St. Martin, Monzr M. Al Malki, Asad Bashey, Sameh Gaballa, Daniel A. Keesler, Mehdi Hamadani, Maxim Norkin, Miguel-Angel Perales, Ran Reshef, Vanderson Rocha, Rizwan Romee, Melhem Solh, Alvaro Urbano-Ispizua, Edmund K. Waller, Ephraim J. Fuchs, Mary Eapen

    Diterbitkan 2018-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?

    Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch? oleh Tara M. Robinson, Ephraim J. Fuchs, Mei-Jie Zhang, Andrew St. Martin, Myriam Labopin, Daniel A. Keesler, Didier Blaise, Asad Bashey, Jean-Henri Bourhis, Fabio Ciceri, Stefan O. Ciurea, Steven M. Devine, Mohamad Mohty, Shannon R. McCurdy, Noel Milpied, Ian K. McNiece, Vanderson Rocha, Rizwan Romee, Gerard Socie, Ibrahim Yakoub-Agha, Robert J. Soiffer, Mary Eapen, Arnon Nagler

    Diterbitkan 2018-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide

    Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide oleh Shannon R. McCurdy, Yvette L. Kasamon, Christopher G. Kanakry, Javier Bolaños-Meade, Hua-Ling Tsai, Margaret M. Showel, Jennifer A. Kanakry, Heather J. Symons, Ivana Gojo, B. Douglas Smith, Maria P. Bettinotti, William H. Matsui, Amy E. Dezern, Carol Ann Huff, Ivan Borrello, Keith W. Pratz, Douglas E. Gladstone, Lode J. Swinnen, Robert A. Brodsky, Mark J. Levis, Richard F. Ambinder, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones, Leo Luznik

    Diterbitkan 2017-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancy

    Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancy oleh Scott R. Solomon, Andrew St. Martin, Nirav N. Shah, Giancarlo Fatobene, Monzr M. Al Malki, Karen K. Ballen, Asad Bashey, Nelli Bejanyan, Javier Bolaños Meade, Claudio G. Brunstein, Zachariah DeFilipp, Richard E. Champlin, Ephraim J. Fuchs, Mehdi Hamadani, Peiman Hematti, Christopher G. Kanakry, Joseph P. McGuirk, Ian K. McNiece, Stefan O. Ciurea, Marcelo C. Pasquini, Vanderson Rocha, Rizwan Romee, Sagar S. Patel, Sumithira Vasu, Edmund K. Waller, John R. Wingard, Mei-Jie Zhang, Mary Eapen

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia

    The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia oleh Justin Kline, Ronald Levy, Joshua Brody, James N. Kochenderfer, Edmund K. Waller, Sundar Jagannath, Michael R. Bishop, David Siegel, David Avigan, Michael Boyiadzis, Jeffrey Miller, Rafat Abonour, Kenneth C. Anderson, Stephen M. Ansell, Lisa Barbarotta, Austin John Barrett, Koen Van Besien, P. Leif Bergsagel, Ivan Borrello, Jill Brufsky, Mitchell Cairo, Ajai Chari, Adam Cohen, Jorge Cortes, Stephen J. Forman, Jonathan W. Friedberg, Ephraim J. Fuchs, Steven D. Gore, Brad S. Kahl, Larry W. Kwak, Marcos de Lima, Mark R. Litzow, Anuj Mahindra, Nikhil C. Munshi, Robert Z. Orlowski, John M. Pagel, David L. Porter, Stephen J. Russell, Karl Schwartz, Margaret A. Shipp, Richard M. Stone, Martin S. Tallman, John M. Timmerman, Frits Van Rhee, Ann Welsh, Michael Werner, Peter H. Wiernik, Madhav V. Dhodapkar

    Diterbitkan 2016-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: